BFM
LEGN icon

Boothbay Fund Management’s Legend Biotech LEGN Stock Holding History

Boothbay Fund Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-65,826
Closed -$1.19M – 2465
2026
Q1 		$1.19M Hold
65,826
– – 0.02% 861
2025
Q4 		$1.43M Buy
+65,826
New +$1.89M 0.02% 678
2024
Q3 		– Sell
-29,905
Closed -$1.32M – 1788
2024
Q2 		$1.32M Buy
+29,905
New +$1.38M 0.03% 625
2023
Q3 		– Sell
-5,546
Closed -$383K – 1918
2023
Q2 		$383K Buy
+5,546
New +$362K 0.01% 1213

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Boothbay Fund Management's LEGN Position: Q2 2026 in Review

Boothbay Fund Management sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 65,826 shares — an estimated $1.19M sold.

Boothbay Fund Management first reported a position in LEGN in Q2 2023 and held it in 4 quarters. The position peaked at $1.43M in Q4 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Boothbay Fund Management reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 65,826 Legend Biotech shares in Q2 2026, an estimated $1.19M.
  • Boothbay Fund Management first reported a position in Legend Biotech in Q2 2023 and held it in 4 quarters.
  • Boothbay Fund Management's Legend Biotech position peaked at $1.43M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.